DORAL, Florida , July 05, 2018 (GLOBE NEWSWIRE) — Earth Science Tech, Inc. (OTC: ETST) (â€śETST” or the â€śCompany”), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development, is pleased to announce the brand name of its innovative MSN-2 medical device.
As mentioned in June, the Company has been working to select a brand name for its MSN-2 medical device. The name that has been selected forÂ ETSTâ€™s leading-edge STI self-sampling kit for women is Hygee, which is the French name for the Goddess of Health and the word for â€śhygieneâ€ť in Greek mythology. While the French name is spelled with an acute accent on the firstÂ â€śeâ€ť (Ă©), the accent will not be used in the brand name.Â The pronunciation of the name will be high-GEE in all markets worldwide. The marketing team, with the help of Absolu Communications, chose the name to reflect the productâ€™s dedication to womenâ€™s health.â€śWe are very pleased with the work that Absolu has done on the name and on Hygeeâ€™s visual identity, including the logo design and the overall graphic signature of the product,â€ť said Nickolas S. Tabraue, an president, director and chairman of ETST. â€śWe anticipate that the registration of the trademark will be officially approved within 10 months, with a 90 percent chance of approval.â€ťIn preparation for Hygeeâ€™s market introduction, a pre-launch clinical study is currently being conducted with Clinique SantĂ© AmitiĂ© in QuĂ©bec, Canada. The results will be announced in the near future.The Company plans to share further updates onÂ its medical device, Hygee; on research and development; and on the Form 10 approval process as eachÂ progresses.About Earth Science Tech, Inc. (ETST)Earth Science Tech, Inc. (â€śETSTâ€ť) offers the highest purity and quality high-grade full spectrum cannabinoid oil on the market. There are positive results in studies on breast cancer and immune cells through the University of Central Oklahoma; in addition toÂ studies through DV Biologics that prove the Companyâ€™s CBD oil formulation lowers cortisol and functions as a neuro-protectant, with positive result case studies through key health organizations. ETST formulates, markets and distributes the CBD oil used for its studies to the public, offering the most effective quality of CBD on the market.
To learn more, please visit: www.EarthScienceTech.comÂ ETST currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:Earth Science Pharmaceutical
Earth Science Pharmaceutical, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc (ETST). Earth Science Pharma, Inc. (“ESP”), which is committed to the development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. ESP’s CEO and chief science officer, Dr. Michel AubĂ©, is leading the companyâ€™s research and development efforts. The companyâ€™s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. ESP is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
To learn more please visit: www.EarthSciencePharmaceutical.comÂ Cannabis Therapeutics
Cannabis Therapeutics, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc. (ETST). Cannabis Therapeutics, Inc. (â€śCTIâ€ť), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds three provisional application patents for a CBD product that is focused on developing treatments for breast and ovarian cancers, as well as two generic CBD based pharmaceutical drugs.
To learn more please visit: www.CannabisThera.com Â KannaBidioiD
KannaBidioid, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc. (ETST). KannaBidioiD, Inc. (â€śKBDâ€ť) provides a wide variety of products geared toward the recreational space of cannabis. KBDâ€™s unique Kanna and CBD formulation is sold and distributed in CBD-infused vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.
To learn more please visit: www.KannaBidioiDInc.comÂ Earth Science Foundation, Inc.
Earth Science Foundation, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc. (ETST). Earth Science Foundation, Inc. (“ESF”), is in the process of becoming a tnonprofit organization to accept grants and donations to conduct further studies and help donate Earth Science Tech, Inc’s effective CBD products to those in need.
To learn more please visit: www.ETSTFoundtion.orgÂ Â SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.Investor Relations Contact:
Dave Demarest 305.546.7640 Office Company Contact:
www.EarthScienceTech.com Nickolas S. Tabraue
President, Director, & Chariman